## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

VALUE thesis: PEG 0.75 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($153.58)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. TradeWell Securities LLC. Purchases 13,697 Shares of Nucor Corporation $NUE**
- Source: MarketBeat | 20251215T132732 | Bullish | Relevance: 100%
- TradeWell Securities LLC significantly increased its stake in Nucor Corporation (NYSE: NUE) by 219.5% in Q2, acquiring an additional 13,697 shares, bringing their total to 19,936 shares valued at $2.583 million. Other major institutional investors like Berkshire Hathaway and Norges Bank also established new positions, raising Nucor's institutional ownership to 76.48%. Despite insider selling activity, Nucor recently increased its quarterly dividend to $0.56, and analysts maintain a "Moderate Buy" rating with an average price target of $171.70.

**2. Thrivent Financial for Lutherans Boosts Stock Position in Nucor Corporation $NUE**
- Source: MarketBeat | 20251214T130822 | Bullish | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Nucor Corporation (NYSE:NUE) by 16.8% in the second quarter, now holding 946,303 shares valued at approximately $122.6 million. This boost comes amidst positive Wall Street sentiment, with analysts maintaining a "Moderate Buy" rating and raising price targets following Nucor's recent earnings beat and dividend hike. Despite some insider selling, institutional investors collectively own 76.48% of the company's stock.

**3. What Every Nucor Investor Should Know Before Buying**
- Source: Finviz | 20251213T124800 | Somewhat-Bullish | Relevance: 100%
- Nucor, a major steelmaker, has seen its stock surge due to strong third-quarter results and increasing demand from large construction projects like data centers and new manufacturing plants. However, investors should be aware that while demand is growing, steelmakers are also increasing supply, which could negatively impact steel pricing and Nucor's profitability in the long term, despite its efficiency. The addition of new mills could lead to lower steel prices.

**4. Berkshire Hathaway Inc Takes $856.79 Million Position in Nucor Corporation $NUE**
- Source: MarketBeat | 20251213T100855 | Bullish | Relevance: 100%
- Berkshire Hathaway Inc has acquired a new stake of 6,614,112 shares in Nucor Corporation, valued at approximately $856.79 million, making it Berkshire's 25th-largest holding. Nucor recently beat earnings estimates with EPS of $2.63 and revenue of $8.52 billion, and analysts project an annual EPS of 7.64. The company also increased its quarterly dividend to $0.56, and Wall Street holds a "Moderate Buy" consensus with a $171.70 target price.

**5. Honeywell adds former PepsiCo CEO Indra Nooyi to board - Bizwomen**
- Source: The Business Journals | 20251215T120820 | Neutral | Relevance: 58%
- Honeywell International Inc. (NASDAQ: HON) has appointed Indra Nooyi, the former CEO of PepsiCo Inc. (NASDAQ: PEP), to its board of directors, effective January 1, 2026. Nooyi, who also serves on Amazon.com Inc.'s (NASDAQ: AMZN) board, brings extensive experience in leading global businesses and will serve as an independent director. This appointment comes as Honeywell undergoes a significant restructuring, including the recent spinoff of its advanced materials business and plans to separate its aerospace and automation businesses next year.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $178 | $167 | +7% |
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | main | Overweight |
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +11%) could attract flows.
- Momentum building: MRS_20 improving +2.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 14.0x attractive for 43% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +11%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.1B |
| Beta | 1.86 |
| 52W Range | $97.59 - $168.07 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 14.0 |
| Current P/E | 20.0 |
| YoY Growth | 43.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.3% to 2.9% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.92% (CS: 58) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.208x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $162.02
- **Stop Loss:** $153.58 (5.2% risk)
- **Target:** $178.90 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 142
- **Position Value:** $23,006.84
- **Portfolio %:** 23.01%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*